🔎 Trials Near Me

Home › Pulmonary Arterial Hypertension › Kansas

Pag-aaral pangklinika para sa Pulmonary Arterial Hypertension sa Kansas

7 pag-aaral para sa Pulmonary Arterial Hypertension ang naghahanap ng mga kalahok sa mga site sa Kansas.

Mga Lungsod sa Kansas

Opisyal na teksto ng pag-aaral (English)

A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

  • USA010, Kansas City
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07481981

An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

  • University of Kansas Medical Center, Kansas City
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07365332

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

  • The University of Kansas Medical Center Research Institute, Kansas City
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT07175038

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

  • University of Kansas Medical Center, Kansas City
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT06274801

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

  • U of Kansas Medical Center, Kansas City
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Hul 21, 2026 · NCT06649110

Pulmonary Hypertension Association Registry

  • KU Medical Center, Kansas City
Nagre-recruitObservasyonal na pag-aaral
Edad 0 pataas · Lahat ng kasarian · Na-update Nob 14, 2025 · NCT04071327

Pulmonary Hypertension Biorepository and Registry

  • University of Kansas Medical Center, Kansas City
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 1, 2025 · NCT04808596

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.